
Home - SOFIE
Your central resource for PET educational materials, including evidence-based publications, clinical case studies, and product resources. Check out the new SOFIE Education Hub Go to the education hub
Who We Are - SOFIE
With our premier radiopharmacy network, mature contract manufacturing services and high value theranostic intellectual property, SOFIE is dedicated to improving patient health.
Careers - SOFIE
Transparency in Coverage (TiC) regulations requires health insurers and group Health Plans to post their provider link on company websites. View SOFIE’s Link here View our Privacy Policy
Network - SOFIE
SOFIE has built a high-capacity PET radiopharmaceutical network capable of delivering large volumes of products to as many patients as possible. Our product lines include FDG, Pylarify, Neuraceq, and …
Team - SOFIE
Our team works alongside our Pharma and Academic partners to revolutionize clinical diagnostics and therapeutics to better understand and treat the biology of disease.
Find a Radiopharmacy - SOFIE
SOFIE is dedicated to providing reliable, high quality radiopharmaceuticals and cutting-edge technologies
SOFIE Biosciences opens PET Manufacturing Facility, expanding service ...
Apr 1, 2025 · With its robust radiopharmaceutical production and distribution network, mature contract manufacturing services, and now, high value Theranostic intellectual property, SOFIE is poised to …
Collaborations - SOFIE
GE HealthCare and SOFIE Biosciences (SOFIE) announced a partnership to develop, manufacture and commercialize SOFIE’s Gallium-68 and Fluorine-18 labelled diagnostics targeting fibroblast …
Focus on FAPI Newsletter - Q2 2025 - SOFIE
Jun 9, 2025 · SOFIE is continuing to accept applications for our FAPI Outreach Program. This program aims to raise awareness and foster collaboration in the field of molecular imaging, specifically …
SOFIE Biosciences Prepares Launch of Two [18F]FAPI-74 Phase 3 …
Oct 1, 2025 · With its robust radiopharmaceutical production and distribution network, mature contract manufacturing services, and now, high-value theranostic intellectual property, SOFIE is poised to …